SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-211191
Filing Date
2013-05-09
Accepted
2013-05-09 16:36:39
Documents
16
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d515003d10q.htm 10-Q 626270
2 EX-10.3 d515003dex103.htm EX-10.3 7903
3 EX-10.4 d515003dex104.htm EX-10.4 833363
4 EX-10.5 d515003dex105.htm EX-10.5 58050
5 EX-10.6 d515003dex106.htm EX-10.6 338524
6 EX-10.7 d515003dex107.htm EX-10.7 64943
7 EX-31.1 d515003dex311.htm EX-31.1 5997
8 EX-31.2 d515003dex312.htm EX-31.2 6059
9 EX-32.1 d515003dex321.htm EX-32.1 4038
16 GRAPHIC g515003exa_logo.jpg GRAPHIC 6119
  Complete submission text file 0001193125-13-211191.txt   5719864

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT gale-20130331.xml EX-101.INS 614550
11 XBRL TAXONOMY EXTENSION SCHEMA gale-20130331.xsd EX-101.SCH 51374
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gale-20130331_cal.xml EX-101.CAL 64809
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gale-20130331_def.xml EX-101.DEF 91554
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE gale-20130331_lab.xml EX-101.LAB 357249
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gale-20130331_pre.xml EX-101.PRE 235306
Mailing Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034
Business Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33958 | Film No.: 13829425
SIC: 2834 Pharmaceutical Preparations